Cell therapy weekly: Washington stem cell clinics must post notice indicating FDA-unapproval
This week: Washington state protects citizens from unproven stem cell therapies, Astellas continues to grow their cell therapy division and Fujifilm-Takeda collaboration will treat heart failure.
Please sign in or register for FREE
Sign in to RegMedNet
Register to RegMedNet
RegMedNet is a free content and networking hub promoting global connection, knowledge-sharing and collaboration between all members of the regenerative medicine field.